CHE Chemed
- 597.420
- -6.750-1.12%
- 585.570
- -11.850-1.98%
Chemed News
Analysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX)
Chemed Analyst Ratings
Chemed Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT), Chemed (CHE) and UnitedHealth (UNH)
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Abbott Labs (ABT) and Chemed (CHE)
Chemed Analyst Ratings
Buy Rating on Chemed Affirmed by Analyst Joanna Gajuk Amidst Vitas Recovery and Strategic Acquisitions
Chemed Analyst Ratings
RBC Raises Price Target on Chemed to $604 From $576, Keeps Outperform Rating
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Teladoc (TDOC) and Vertex Pharmaceuticals (VRTX)
Oppenheimer Sticks to Its Buy Rating for Chemed (CHE)
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Phibro Animal Health (PAHC) and Catalent (CTLT)
Chemed Analyst Ratings
RBC Cuts Price Target on Chemed to $576 From $610, Maintains Outperform Rating
Oppenheimer Maintains Outperform on Chemed, Lowers Price Target to $590
Chemed Analyst Ratings
Oppenheimer Adjusts Chemed Price Target to $590 From $610, Maintains Outperform Rating
Analysts Conflicted on These Healthcare Names: Align Tech (ALGN), Chemed (CHE) and Icon (ICLR)
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Genmab (GMAB) and Matinas BioPharma (MTNB)
Analysis
Price Target
No Data
